Cytek Biosciences, Inc. ( CTKB ) Beats Q2 Earnings Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of +150.00% and -3.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
IRVINE, CA, and HERSTAL, BELGIUM - July 3, 2025 ( GlobeNewswire ) - MDxHealth SA ( NASDAQ: MDXH ) ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee.
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change - MDxHealth ( NASDAQ:MDXH ) , Cytek Biosciences ( NASDAQ:CTKB )
IRVINE, CA, and HERSTAL, BELGIUM - July 3, 2025 ( GlobeNewswire ) - MDxHealth SA MDXH ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the appointment of Michael Holder to its Board of Directors as the Chair of the Audit Committee.
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., May 29, 2025 ( GLOBE NEWSWIRE ) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. CTKB today announced the launch of the Cytek Aurora™ Evo system, a new full spectrum flow cytometer that improves on its flagship Cytek ...
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
FREMONT, Calif., May 28, 2025 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. ( Nasdaq: CTKB ) , a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 46th Annual Global Healthcare Conference in Miami Beach, FL.
DHT Holdings Posts Weak Sales, Joins Compass Diversified, Okta And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Cytek Biosciences ( NASDAQ:CTKB ) , Compass Diversified Hldgs ( NYSE:CODI )
U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Wednesday. Shares of DHT Holdings, Inc. DHT fell sharply in pre-market trading following downbeat quarterly sales. DHT Holdings reported quarterly earnings of 27 cents per share which beat the analyst ...
Cytek Biosciences, Inc. ( CTKB ) Reports Q1 Loss, Lags Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -125% and 5.07%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Generation Bio Co. ( GBIO ) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of 12% and 464.23%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025 - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., April 29, 2025 ( GLOBE NEWSWIRE ) -- Continuing its commitment to advancing cell analysis, Cytek Biosciences, Inc. CTKB is showcasing its patented Full Spectrum Profiling™ ( FSP® ) technology at CYTO 2025 and American Association of Immunologists' ( AAI ) IMMUNOLOGY2025.
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Cytek Biosciences is showcasing its patented Full Spectrum Profiling™ technology at CYTO 2025 & American Association of Immunologists' ...
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., March 18, 2025 ( GLOBE NEWSWIRE ) -- Today, Cytek Biosciences, Inc. CTKB announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell analyzer, creating a next-generation instrument called the Cytek® Muse® Micro.
Cytek Biosciences, Inc. ( CTKB ) Tops Q4 Earnings Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of 16.67% and 9.49%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Dynavax Technologies ( DVAX ) Surpasses Q4 Earnings and Revenue Estimates
Dynavax Technologies (DVAX) delivered earnings and revenue surprises of 25% and 0.46%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference
FREMONT, Calif., Jan. 02, 2025 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. ( Nasdaq: CTKB ) , a leading cell analysis solutions company, today announced the company will be participating in the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November - Cytek Biosciences ( NASDAQ:CTKB ) , CEL-SCI ( AMEX:CVM )
U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.7% on Monday. The Dow traded down 0.67% to 42,702.02 while the NASDAQ fell 0.73% to 19,578.50. The S&P 500 also fell, dropping, 0.72% to 5,928.08. In trading on Monday, consumer discretionary shares dipped by ...
Crude Oil Gains 1%; Chicago PMI Falls In December - Cytek Biosciences ( NASDAQ:CTKB ) , CEL-SCI ( AMEX:CVM )
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 100 points on Monday. The Dow traded down 0.61% to 42,725.52 while the NASDAQ fell 0.58% to 19,608.47. The S&P 500 also fell, dropping, 0.59% to 5,935.35. Energy shares fell by just 0.6% on Monday.
Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Akso Health ( NASDAQ:AHG ) , Antero Resources ( NYSE:AR )
U.S. stocks were lower, with the Dow Jones index falling more than 700 points on Monday. Shares of Cytek Biosciences, Inc. CTKB rose sharply during Monday's session. Cytek Biosciences announced a $50 million stock buyback program for 2025. Cytek Biosciences shares jumped 6.1% to $6.78 on Monday.
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
Cytek Biosciences Announces $50 Million Stock Repurchase Program for ...
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., Nov. 20, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB, a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 36th Annual Healthcare Conference in New York, NY.
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference
FREMONT, Calif., Nov. 20, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. ( Nasdaq: CTKB ) , a leading cell analysis solutions company, today announced the company will be participating in the upcoming Piper Sandler 36th Annual Healthcare Conference in New York, NY.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., Nov. 07, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB has introduced an Enhanced Small Particle ( ESP™ ) Detection Option for its Cytek Aurora™ CS system.
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
Cytek has introduced the world's first Enhanced Small Particle (ESP™) Detection Sorter, which opens the door to scientific discoveries.
Nasdaq Surges Over 500 Points; Johnson Controls Earnings Top Views - Johnson Controls Intl ( NYSE:JCI )
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 500 points on Wednesday. The Dow traded up 3.45% to 43,678.43 while the NASDAQ rose 2.84% to 18,963.41. The S&P 500 also rose, gaining, 2.44% to 5,923.85. Financial shares surged by 5.9% on Tuesday.
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results - Sunnova Energy Intl ( NYSE:NOVA )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 2% on Wednesday. The Dow traded up 3.17% to 43,561.18 while the NASDAQ rose 2.23% to 18,849.87. The S&P 500 also rose, gaining, 1.95% to 5,895.66. Financial shares surged by 5.3% on Tuesday.
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday - Mercury Sys ( NASDAQ:MRCY )
U.S. stocks were higher, with the Dow Jones index gaining around 1,300 points on Wednesday. Shares of Mercury Systems, Inc. MRCY rose sharply during Wednesday's session after the company reported better-than-expected quarterly financial results.
Cytek Biosciences, Inc. ( CTKB ) Q3 Earnings and Revenues Beat Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of 150% and 1.72%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Codexis ( CDXS ) Reports Q3 Loss, Tops Revenue Estimates
Codexis (CDXS) delivered earnings and revenue surprises of -16% and 10.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Cytek® Biosciences Brings Full Spectrum Profiling™ ( FSP™ ) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., Sept. 18, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB is set to elevate its presence at this year's premier clinical industry events across the globe.
Cytek® Biosciences Brings Full Spectrum Profiling™ ( FSP™ ) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe
Cytek to spotlight its Full Spectrum Profiling technology and advanced cell analysis solutions at ICCS and ESCCA.
Cytek Announces Resignation of Chief Operating Officer Chris Williams - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB, a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a CEO position at another company.
Cytek Announces Resignation of Chief Operating Officer Chris Williams
FREMONT, Calif., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. ( Nasdaq: CTKB ) , a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a CEO position at another ...
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
Cytek announced that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification.
Cytek Biosciences, Inc. ( CTKB ) Reports Q2 Loss, Lags Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of -166.67% and 4.89%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., July 30, 2024 ( GLOBE NEWSWIRE ) -- Today Cytek Biosciences, Inc. CTKB announced that it has developed a revolutionary tool to automate panel design.
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
Cytek has developed a revolutionary tool to automate panel design. SpectroPanel is an intelligent algorithm that suggests optimized panels in minutes.
Cytek Biosciences ( CTKB ) Moves 5.1% Higher: Will This Strength Last?
Cytek Biosciences (CTKB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., May 30, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB, a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL.
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., May 28, 2024 ( GLOBE NEWSWIRE ) -- Today Cytek Biosciences, Inc.
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
Cytek announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China NMPA approval for for clinical diagnostic use.
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., May 20, 2024 ( GLOBE NEWSWIRE ) -- Today Cytek Biosciences, Inc. CTKB, a leading cell analysis solutions company, officially announced its Enhanced Small Particle ( ESP™ ) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek has announced its Enhanced Small Particle Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates - AnaptysBio ( NASDAQ:ANAB ) , Cytek Biosciences ( NASDAQ:CTKB )
Cytek Biosciences, Inc. CTKB came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings ...
Cytek Biosciences, Inc. ( CTKB ) Reports Q1 Loss, Tops Revenue Estimates
Cytek Biosciences (CTKB) delivered earnings and revenue surprises of 80% and 2.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Axsome ( AXSM ) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Axsome's (AXSM) bottom line declines year over year in the first quarter. Strong sales of Auvelity drive revenues.
Cytek Biosciences, Inc. ( CTKB ) Stock Moves -0.33%: What You Should Know
In the most recent trading session, Cytek Biosciences, Inc. (CTKB) closed at $6.01, indicating a -0.33% shift from the previous trading day.
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe - Cytek Biosciences ( NASDAQ:CTKB )
FREMONT, Calif., April 30, 2024 ( GLOBE NEWSWIRE ) -- Cytek Biosciences, Inc. CTKB, a leading cell analysis solutions company, continues its commitment to advancing the cell analysis market by actively participating in key industry gatherings worldwide.
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
Cytek® Biosciences will spotlight its cell analysis solutions and conduct educational workshops/tutorials at CYTO and ...
Cytek Biosciences ( CTKB ) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for Cytek Biosciences (CTKB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Cytek Biosciences ( CTKB ) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Cytek Biosciences (CTKB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
Wall Street Analysts Believe Cytek Biosciences ( CTKB ) Could Rally 47.61%: Here's is How to Trade
The consensus price target hints at a 47.6% upside potential for Cytek Biosciences (CTKB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
